COVID-19 vaccine-induced guillain-barre syndrome
First case of severe acute respiratory syndrome coronavirus-2 was detected in Wuhan province of china. Within a year, the vaccine development process accelerated and emergency approval was rolled out for vaccines. Covishield, an adenovirus vector-based vaccine manufactured by Serum Institute of Indi...
Sparad:
| Huvudupphov: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Serie: | Journal of the Scientific Society |
| Ämnen: | |
| Länkar: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2024;volume=51;issue=1;spage=105;epage=107;aulast=Sajan |
| Taggar: |
Inga taggar, Lägg till första taggen!
|